DRG Epidemiology’s global epidemiology forecast for pancreatic cancer offers 10 year (20 years in the G7) epidemiological forecasts for 45 countries, covering 90% of the world’s population for all of the following pancreatic cancer patient populations:
In addition, estimates of the drug-treated prevalent population are also available for United States, France, Germany, Italy, Spain, United Kingdom and Japan.
DRG Epidemiology’s estimates are presented in DRG’s Insights Platform, allowing the user to easily navigate between world regions and patient populations, as well as download the data in Excel formatted files.
All of our epidemiological forecasts are accompanied by a transparent description of our forecast methods and data sources, the details of our systematic review underlying each forecast and associated summary evidence tables, and access to the authoring epidemiologist. All epidemiological forecasts may be supplemented with custom deliverables, such as: